000 01967nam  2200325za 4500
0019.825318
003CaOODSP
00520221107144328
007cr |||||||||||
008161003s2016    onc     ob   f000 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-9/2016-26E-PDF
24500|aBacillus mycoides isolate J |h[electronic resource].
260 |aOttawa : |bHealth Canada, |cc2016.
300 |a44 p.
4901 |aProposed registration decision, |x1925-0886 ; |vPRD2016-26
500 |aIssued also in French under title: Isolat J de Bacillus mycoides.
500 |a"28 September 2016.”
504 |aIncludes references.
520 |a"Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing full registration for the sale and use of BmJ TGAI and BmJ WG, containing the technical grade active ingredient Bacillus mycoides isolate J, for the suppression or partial suppression of certain fungal diseases on food crops. An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. This Overview describes the key points of the evaluation, while the Science Evaluation provides detailed technical information on the human health, environmental and value assessments of BmJ TGAI and BmJ WG"--Overview.
530 |aIssued also in printed form.
69207|2gccst|aPesticides
69207|2gccst|aCertification
69207|2gccst|aToxicology
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tIsolat J de Bacillus mycoides |w(CaOODSP)9.825321
830#0|aProposed registration decision,|x1925-0886 ; |vPRD2016-26|w(CaOODSP)9.504464
85640|qPDF|s361 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H113-9-2016-26-eng.pdf